Spirit Health said on social media that it plans to make a new continuous glucose monitor (CGM) available next month.

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A ...

By Christy Santhosh (Reuters) -Dexcom forecast total annual revenue largely in line with Wall Street expectations on Monday, on bets there will be strong demand for its continuous glucose monitors for ...

Argentina Diabetes Devices Market To Reach US$ 1,031.89 Million By 2033, Growing At A CAGR Of 7.48% Astute Analytica ...

Dexcom forecast total annual revenue in line with Wall Street expectations on Monday, on bets of strong demand for its continuous glucose monitors for diabetes patients, sending the medical device ...

Inhaled insulin was noninferior to usual care in glycemic control outcomes after 17 weeks among patients with type 1 diabetes.

As we kick off the new year, it’s a great time to focus on your health.

TD Cowen analyst Josh Jennings reiterated a Buy rating on Dexcom (DXCM – Research Report) today and set a price target of $100.00. The ...

Shares of Lululemon Athletica Inc. ( LULU-Q +0.65% ) started lower on Monday after it raised its current-quarter targets, as ...

Recent advances in immunotherapy have revealed a promising frontier in Type 1 diabetes treatment: outsmarting rather than ...

CES 2025 delivered groundbreaking innovations, from agentic AI and Blockchain to health tech and humanoid robotics, ...

AI tech is making significant improvements in the medical field, and now, it's also inspiring a shift in focus from treatment ...